These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 4177000)
21. Different ratios of the LDD and DDD diastereoisomers of phytanic acid in patients with Refsum's disease. Eldjarn L; Try K Biochim Biophys Acta; 1968 Sep; 164(1):94-100. PubMed ID: 4176022 [No Abstract] [Full Text] [Related]
24. [Studies on the metabolism of phytol, dihydrophytol and phytanic acid]. Klenk E; Kremer GJ Hoppe Seylers Z Physiol Chem; 1965; 343(1):39-51. PubMed ID: 4161137 [No Abstract] [Full Text] [Related]
25. Occurrence of novel branched-chain fatty acids in Refsum's disease. Dulaney JT; Williams M; Evans JE; Costello CE; Kolodny EH Biochim Biophys Acta; 1978 Apr; 529(1):1-12. PubMed ID: 76480 [TBL] [Abstract][Full Text] [Related]
26. Alpha-oxidation of branched chain fatty acids in man and its failure in patients with Refsum's disease showing phytanic acid accumulation. Eldjarn L; Stokke O; Try K Scand J Clin Lab Invest; 1966; 18(6):694-5. PubMed ID: 4163668 [No Abstract] [Full Text] [Related]
27. [Studies on the phytol metabolism in lipoidosis heredopathia atactica polyneuritiformis (Refsum's syndrome). The transformation of 3H-phytol into the 3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) of the plasma lipoid fractions]. Kahlke W; Wagener H; Dieckmann H Klin Wochenschr; 1965 Dec; 43(24):1345-7. PubMed ID: 4163289 [No Abstract] [Full Text] [Related]
30. Di-, mono- and nonphytanyl triglycerides in the serum: a sensitive parameter of the phytanic acid accumulation in Refsum's disease. Molzer B; Bernheimer H; Barolin GS; Höfinger E; Lenz H Clin Chim Acta; 1979 Jan; 91(2):133-40. PubMed ID: 83207 [TBL] [Abstract][Full Text] [Related]
31. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease. Yao JK; Dyck PJ Lipids; 1987 Feb; 22(2):69-75. PubMed ID: 2436023 [TBL] [Abstract][Full Text] [Related]
33. [At the meeting point of lipidosis and hereditary neuropathies: Refsum's disease]. Wolf LM; Laudat P Ann Biol Clin (Paris); 1969; 27(7):549-58. PubMed ID: 4187679 [No Abstract] [Full Text] [Related]
34. Alpha-oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease. Stokke O; Try K; Eldjarn L Biochim Biophys Acta; 1967 Oct; 144(2):271-84. PubMed ID: 4168936 [No Abstract] [Full Text] [Related]
35. The nature of the metabolic defect in Refsum's disease. Steinberg D; Avigan J; Mize CE; Herndon JH; Fales HM; Milne GW Pathol Eur; 1968; 3(2):450-8. PubMed ID: 4176998 [No Abstract] [Full Text] [Related]
36. Refsum's syndrome. Levy IS Trans Ophthalmol Soc U K (1962); 1970; 90():181-6. PubMed ID: 4104195 [No Abstract] [Full Text] [Related]
37. Studies on the biochemical defect in heredopathia atactica polyneuritiformis (Refsum's disease). Eldjarn L; Try K; Stokke O Pathol Eur; 1968; 3(2):459-67. PubMed ID: 4176999 [No Abstract] [Full Text] [Related]
38. Phytyl fatty acid esters in vegetables pose a risk for patients suffering from Refsum's disease. Krauß S; Michaelis L; Vetter W PLoS One; 2017; 12(11):e0188035. PubMed ID: 29131855 [TBL] [Abstract][Full Text] [Related]